Adia Med Inc (ADIA) Financials

Adia Med Inc (ADIA) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Adia Med Inc (ADIA) had EBITDA of -$362K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Adia Med Inc (ADIA) had a gross margin of 27.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Adia Med Inc (ADIA) had an operating margin of -52.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Adia Med Inc (ADIA) had a net profit margin of -56.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Adia Med Inc (ADIA) recorded an outflow of $192K in free cash flow during fiscal year 2025. This represents a 46.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Adia Med Inc (ADIA) recorded an outflow of $179K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Adia Med Inc (ADIA) had $595K in total assets as of fiscal year 2025, including both current and long-term assets.

Adia Med Inc (ADIA) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Adia Med Inc (ADIA) invested $29K in research and development during fiscal year 2025.

Adia Med Inc (ADIA) had 94M shares outstanding as of fiscal year 2025.

Adia Med Inc (ADIA) had a current ratio of 0.22 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Adia Med Inc (ADIA) had a return on assets of -66.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Adia Med Inc (ADIA) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $12.3M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Adia Med Inc (ADIA) trades at 17.5x sales, its market capitalization divided by revenue of $701K revenue, FY2025. The market capitalization is $12.3M as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Adia Med Inc (ADIA) held $79K in cash, cash equivalents and investments, and reported an operating cash outflow of $179K over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Adia Med Inc (ADIA) has negative shareholder equity of -$258K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Adia Med Inc (ADIA) has an Altman Z-Score of -30.99, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Adia Med Inc (ADIA) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Adia Med Inc (ADIA) reported a net loss of $395K while operations used $179K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Adia Med Inc (ADIA) reported an operating loss of $366K against $32K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.